Zeo ScientifiX, Inc. SEC filings ZEOX
Zeo ScientifiX, Inc. has 518 filings in SEC EDGAR's recent list, going back to Sep 4, 2012. Its latest annual report, Form 10-KT, was filed on Oct 13, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on Jun 15, 2026, covering the quarter ended Apr 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (other events). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 30, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Material agreement
|
Oct 26, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 15, 2026 | Sep 10, 2026 |
| 8-K |
Current report
Other events
|
Sep 15, 2026 | Sep 15, 2026 |
| 8-K |
Current report
Other events
|
Sep 1, 2026 | Sep 1, 2026 |
| 8-K |
Current report
Other events
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Other events
|
Jul 21, 2026 | Jul 21, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 8, 2026 | Jul 8, 2026 |
| 8-K |
Current report
Other events
|
Jul 1, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Other events
|
Jun 16, 2026 | Jun 16, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 12, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Other events
|
Jun 9, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Other events
|
May 27, 2026 | May 27, 2026 |
| 8-K |
Current report
Other events
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Other events
|
Apr 21, 2026 | Apr 21, 2026 |
| 8-K |
Current report
Other events
|
Apr 9, 2026 | Apr 9, 2026 |
| 8-K |
Current report
Other events
|
Apr 7, 2026 | Apr 7, 2026 |
| 8-K |
Current report
Other events
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 27, 2026 | Mar 23, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 28, 2026 | Jan 23, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 21, 2026 | Jan 14, 2026 |
| 8-K |
Current report
Other events
|
Jan 7, 2026 | Jan 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 5, 2026 | Dec 24, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 3, 2025 | Nov 30, 2025 |
| 8-K |
Current report
Other events
|
Oct 23, 2025 | Oct 23, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Jul 29, 2025 | Jul 25, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 21, 2025 | Jul 18, 2025 |
| 8-K |
Current report
Other events
|
Jul 9, 2025 | Jul 9, 2025 |
| 8-K |
Current report
Other events
|
Jun 24, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
May 12, 2025 | May 8, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2025 | Apr 1, 2025 |
| 8-K |
Current report
Other events
|
Feb 18, 2025 | Feb 18, 2025 |
| 8-K |
Current report
Other events
|
Feb 11, 2025 | Feb 11, 2025 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Feb 10, 2025 | Feb 4, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 19, 2024 | Dec 17, 2024 |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
Nov 22, 2024 | Nov 15, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 15, 2024 | Nov 15, 2024 |
| 8-K |
Current report
Other events
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Other events
|
Oct 15, 2024 | Oct 15, 2024 |
| 8-K |
Current report
Other events
|
Sep 30, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Sep 20, 2024 | Sep 20, 2024 |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
Aug 7, 2024 | Jul 11, 2024 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Jul 12, 2024 | Jul 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 3, 2024 | May 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Other events
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 26, 2024 | Feb 20, 2024 |
| 8-K |
Current report
Other events
|
Dec 12, 2023 | Dec 8, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Nov 27, 2023 | Nov 27, 2023 |
| 8-K |
Current report
Other events
|
Nov 14, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Acquisition or sale of assets
|
Aug 9, 2023 | Aug 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 26, 2023 | Jul 26, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 11, 2023 | Jul 11, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 29, 2023 | Jun 29, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 21, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Other events
|
Jun 9, 2023 | Jun 7, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 6, 2023 | Jun 4, 2023 |
| 8-K |
Current report
Officer or director change
|
May 15, 2023 | May 12, 2023 |
| 8-K |
Current report
Officer or director change
|
May 1, 2023 | Apr 28, 2023 |
| 8-K |
Current report
Auditor change
|
Apr 21, 2023 | Apr 17, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 8, 2023 | Mar 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 23, 2022 | Dec 21, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 1, 2022 | Nov 29, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 25, 2022 | Nov 22, 2022 |
| 8-K |
Current report
Other events
|
Nov 21, 2022 | Nov 21, 2022 |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
Oct 12, 2022 | Oct 12, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 12, 2022 | Oct 12, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 27, 2022 | Sep 23, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 20, 2022 | Sep 20, 2022 |
| 8-K |
Current report
Other events
|
Sep 16, 2022 | Sep 16, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 15, 2022 | Sep 13, 2022 |
| 8-K |
Current report
Unregistered share sale, Officer or director change, Other events
|
Sep 9, 2022 | Sep 7, 2022 |
| 8-K |
Current report
Material agreement
|
Sep 6, 2022 | Sep 1, 2022 |
| 8-K |
Current report
Other events
|
Aug 30, 2022 | Aug 30, 2022 |
| 8-K |
Current report
Other events
|
Aug 26, 2022 | Aug 26, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Bylaw or fiscal year change
|
Aug 23, 2022 | Aug 19, 2022 |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
Jul 26, 2022 | Jul 21, 2022 |
| 8-K |
Current report
Other events
|
Jul 20, 2022 | Jul 20, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 19, 2022 | Jul 13, 2022 |
| 8-K |
Current report
Other events
|
Feb 8, 2022 | Feb 8, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jan 13, 2022 | Jan 11, 2022 |
| 8-K |
Current report
Other events
|
Dec 29, 2021 | Dec 29, 2021 |
| 8-K |
Current report
Other events
|
Nov 9, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Other events
|
Nov 5, 2021 | Nov 5, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 2, 2021 | Oct 29, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 31, 2021 | Aug 30, 2021 |
| 8-K |
Current report
Other events
|
Jul 21, 2021 | Jul 21, 2021 |
| 8-K |
Current report
Other events
|
Jul 13, 2021 | Jun 17, 2021 |
| 8-K |
Current report
Other events
|
Jun 15, 2021 | Jun 15, 2021 |
| 8-K |
Current report
Other events
|
Jun 9, 2021 | Jun 9, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
May 25, 2021 | May 25, 2021 |
| 8-K |
Current report
Other events
|
May 19, 2021 | May 19, 2021 |
| 8-K |
Current report
Other events
|
May 11, 2021 | May 11, 2021 |
| 8-K |
Current report
Other events
|
May 4, 2021 | May 4, 2021 |
| 8-K |
Current report
Other events
|
Apr 28, 2021 | Apr 28, 2021 |
| 8-K |
Current report
Other events
|
Apr 22, 2021 | Apr 22, 2021 |
| 8-K |
Current report
Other events
|
Apr 21, 2021 | Apr 21, 2021 |
| 8-K |
Current report
Other events
|
Apr 14, 2021 | Apr 14, 2021 |
| 8-K |
Current report
Other events
|
Mar 23, 2021 | Mar 23, 2021 |
| 8-K |
Current report
Other events
|
Mar 18, 2021 | Mar 18, 2021 |
| 8-K |
Current report
Other events
|
Jan 28, 2021 | Jan 28, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2021 | Jan 12, 2021 |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
Dec 28, 2020 | Dec 21, 2020 |
| 8-K |
Current report
Other events
|
Dec 22, 2020 | Dec 22, 2020 |
| 8-K |
Current report
Other events
|
Nov 18, 2020 | Nov 18, 2020 |
| 8-K |
Current report
Other events
|
Nov 12, 2020 | Nov 12, 2020 |
| 8-K |
Current report
Other events
|
Oct 20, 2020 | Oct 20, 2020 |
| 8-K |
Current report
Unregistered share sale, Officer or director change, Other events
|
Sep 30, 2020 | Sep 23, 2020 |
| 8-K |
Current report
Other events
|
Sep 2, 2020 | Sep 2, 2020 |
| 8-K |
Current report
Other events
|
Aug 20, 2020 | Aug 20, 2020 |
| 8-K |
Current report
Other events
|
Aug 18, 2020 | Aug 18, 2020 |
| 8-K |
Current report
Other events
|
Aug 13, 2020 | Aug 13, 2020 |
| 8-K |
Current report
Other events
|
Aug 6, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Unregistered share sale, Officer or director change, Bylaw or fiscal year change
|
Jul 14, 2020 | Jun 24, 2020 |
| 8-K |
Current report
Other events
|
May 27, 2020 | May 27, 2020 |
| 8-K |
Current report
Unregistered share sale, Officer or director change, Other events
|
May 19, 2020 | May 19, 2020 |
| 8-K |
Current report
Other events
|
May 5, 2020 | May 5, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Apr 30, 2020 | Mar 30, 2020 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 21, 2020 | Apr 2, 2020 |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
Mar 11, 2020 | Feb 26, 2020 |
| 8-K |
Current report
Other events
|
Jan 23, 2020 | Jan 21, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 26, 2019 | Sep 24, 2019 |
| 8-K |
Current report
Officer or director change
|
Sep 17, 2019 | Sep 11, 2019 |
| 8-K |
Current report
Officer or director change
|
Aug 29, 2019 | Aug 14, 2019 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
May 2, 2019 | Feb 7, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 27, 2018 | Dec 21, 2018 |
| 8-K |
Current report
Auditor change
|
Aug 16, 2018 | Aug 13, 2018 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jun 25, 2018 | Jun 20, 2018 |
| 8-K |
Current report
Officer or director change
|
May 30, 2018 | May 29, 2018 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Other events
|
Apr 26, 2018 | Apr 23, 2018 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Apr 12, 2018 | Apr 6, 2018 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change
|
Feb 9, 2018 | Feb 5, 2018 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 18, 2017 | Dec 13, 2017 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
May 23, 2017 | May 17, 2017 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Apr 3, 2017 | Mar 29, 2017 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Other events
|
Mar 15, 2017 | Mar 8, 2017 |
| 8-K |
Current report
Material agreement
|
Feb 23, 2017 | Feb 14, 2017 |
| 8-K |
Current report
Other events
|
Jan 12, 2017 | Jan 12, 2017 |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
Nov 14, 2016 | Nov 4, 2016 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Other events
|
Nov 3, 2016 | Nov 1, 2016 |
| 8-K |
Current report
Agreement ended
|
Mar 21, 2016 | Feb 23, 2016 |
| 8-K |
Current report
Agreement ended
|
Nov 20, 2015 | Nov 18, 2015 |
| 8-K |
Current report
Acquisition or sale of assets, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change
|
Nov 3, 2015 | Oct 30, 2015 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 13, 2015 | Aug 7, 2015 |
| 8-K/A |
Amended current report
Other events
|
Sep 21, 2015 | Sep 17, 2015 |
| 8-K |
Current report
Other events
|
Sep 17, 2015 | Sep 17, 2015 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 4, 2015 | Aug 11, 2015 |
| 8-K |
Current report
Auditor change
|
Jul 31, 2015 | Jul 27, 2015 |
| 8-K |
Current report
Material agreement, Change in control
|
Jun 25, 2015 | Jun 24, 2015 |
| 8-K |
Current report
Material agreement, Change in control, Officer or director change, Other events
|
Jun 2, 2015 | May 29, 2015 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 27, 2015 | May 26, 2015 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 2, 2015 | Feb 19, 2015 |
| 8-K |
Current report
Auditor change
|
Aug 7, 2014 | Aug 4, 2014 |
| 8-K |
Current report
Restatement
|
Jul 7, 2014 | Jun 25, 2014 |
Showing 155 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ZEOX (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- NV
- Headquarters
- Davie, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1557376
- Former names
- Organicell Regenerative Medicine, Inc. (until Jan 29, 2024); Biotech Products Services & Research, Inc. (until Jun 15, 2018); BESPOKE TRICYCLES INC (until Sep 14, 2015)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.